Three-drug treatment regimen shows promise for difficult-to-treat brain lymphoma
A collaborative clinical study led by National Taiwan University Hospital (NTUH) and Taiwan Clinical Oncology Group, National Health Research Institutes (TCOG, NHRI) has yielded promising results for a new therapeutic regimen to treat primary central nervous system lymphoma (PCNSL), a rare and aggressive cancer that develops in the brain or other parts of the central nervous system.
We haven't written up this one. Medical Xpress has the full story — the link below goes straight to it.
